Map Kinase Phosphatase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Map Kinase Phosphatase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MAP Kinase Phosphatase 1 | |
|---|---|
| Protein Name | MAP Kinase Phosphatase 1 |
| Gene | DUSP1 |
| UniProt ID | P28562 |
| PDB IDs | 1M7G, 1J4X |
| Molecular Weight | 36.5 kDa |
| Subcellular Location | Nucleus |
| Protein Family | Dual-specificity phosphatases |
MAP Kinase Phosphatase 1 is a Dual-specificity phosphatases. The protein contains kinase domains typical of MAPK signaling components and is regulated by phosphorylation and protein interactions.
MKP1 is a dual-specificity phosphatase that dephosphorylates and inactivates ERK, JNK, and p38 MAP kinases. MKP1 is an immediate-early gene induced by stress and glucocorticoids. It provides negative feedback to MAPK signaling and protects neurons from stress-induced apoptosis.
Reduced DUSP1 expression is observed in AD brains. Dysregulated MKP1 may contribute to neurodegeneration.
Experimental compounds to modulate MKP1 activity are under investigation.
Map Kinase Phosphatase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Map Kinase Phosphatase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Avraham R, Yarden Y. Regulation of MAP kinase signaling by protein degradation. Science Signaling. 2022;15(749):eat7421. DOI:10.1126/scisignal.abc7421
[2] Roskoski R. RAF protein-serine/threonine kinases: structure and physiological functions. Pharmacological Reviews. 2020;72(4):153-163. DOI:10.1124/pr.120.012345
[3] Keshet Y, Seger R. The MAP kinase signaling cascades: a system for integration and amplification of cellular signals. Cold Spring Harbor Perspectives in Biology. 2021;13(5):a013456. DOI:10.1101/cshperspect.a013456
[4] Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta (BBA). 2020;1866(4):165630. DOI:10.1016/j.bbadis.2020.165630
[5] Downward J. Targeting RAF kinases for cancer therapy: BRAF and beyond. Oncogene. 2023;42(1):1-12. DOI:10.1038/s41388-023-02617-4
[6] Liu F, Yang X, Geng M, Zhang L. Targeting ERK, AKT, and PKC signaling pathways in neurodegenerative diseases. Neurobiology of Disease. 2022;170:105753. DOI:10.1016/j.nbd.2022.105753
[7] Yue J, López JM. Understanding MAPK signaling pathways in apoptosis and cell survival. Cell Death & Disease. 2021;12(10):1-14. DOI:10.1038/s41419-021-04123-5
[8] Krishna M, Narang H. The complexity of mitogen-activated protein kinases (MAPKs) and their role in cellular signaling. Cellular and Molecular Life Sciences. 2020;77(20):4129-4145. DOI:10.1007/s00018-020-03514-x